Vision Impairment in the National Health and Aging Trends Study: Epidemiology, Social Determinants of Health, and Adverse Late Life Outcomes
国家健康和老龄化趋势研究中的视力障碍:流行病学、健康的社会决定因素和不良的晚年结局
基本信息
- 批准号:10730418
- 负责人:
- 金额:$ 66.16万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-30 至 2028-06-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAdmission activityAdoptedAdultAffectAged, 80 and overAgingBlack PopulationsBlindnessCollaborationsComplementComplexContrast SensitivityDataDementiaDevelopmentDiagnosisEconomicsElderlyEpidemiologyEthnic OriginEthnic PopulationEyeEye diseasesFundingGrowthHealthHealth care facilityHealthcare SystemsHispanic PopulationsImpairmentIncidenceIndividualLinkLong-Term CareMeasurementMeasuresMediatingMediationMedicareMedicare claimMissionModelingNational Eye InstituteNeighborhoodsOutcomePersonal SatisfactionPersonsPoliciesPopulationPrevalenceProtocols documentationPublic HealthPublic PolicyRaceReportingResearchResearch PersonnelResearch SupportRisk FactorsSample SizeSamplingStrategic PlanningSurveysSystemTestingTimeUnited States National Institutes of HealthValidationVisionVision TestsVisualVisual AcuityVisual impairmentWorkadverse outcomeage groupage stratificationbeneficiaryblindbuilt environmentcomorbiditycontextual factorsdata archivedemographicsdisabilitydissemination strategyepidemiologic dataethnic minorityexperiencehealth care availabilityhealth disparityhealth equityhuman old age (65+)insightinterestlongitudinal analysismortalitynovelpopulation basedprospectiveracial minorityracial minority populationsexsocial health determinantssocial mediasocioeconomicssymposiumtrend
项目摘要
PROJECT SUMMARY/ABSTRACT
At least 14 million people in the U.S. are blind or living with a vision impairment (VI), and the number
affected is projected to double by 2050 due to aging and growth of the U.S. population. The majority
of those with VI and blindness are older adults aged ≥65 years. Racial and ethnic minorities are also
disproportionately affected, in part due to social determinants of health (SDoH) like healthcare
access, economic stability, and features of the built environment. Particularly in later life, VI is thought
to be associated with a host of adverse outcomes, including dementia, admission to a long-term care
facility, and even mortality. Nonetheless, rigorous and generalizable research on how SDoH impact
vision and eye health, and how vision influences late-life outcomes has been limited due to a lack of
data that: (i) is longitudinal; (ii) is representative of the U.S. population; (iii) contains objective
assessments of visual function; and (iv) samples older adults. In the proposed project, we will
address this barrier using newly collected vision data from the NIH-funded National Health and Aging
Trends Study (NHATS), an ongoing nationally representative panel study of >7,000 adults aged ≥65
years. In 2021, NHATS began annual measurement of distance and near visual acuity and contrast
sensitivity. In Aim 1 of the proposed study, we use NHATS data to provide the first-ever estimates on
the incidence of VI and blindness at the national level, as well as national prevalence estimates
stratified by age, sex, and race and ethnicity. In Aim 2, we will evaluate the longitudinal influence of
SDoH on vision health. To do so, we will utilize individual-level indicators of SDoH from NHATS, and
neighborhood level-indicators from the NIH-funded National Neighborhood Data Archive that is linked
to NHATS. In Aim 3, we will investigate the longitudinal impact of VI and blindness on the
development of dementia, placement in long-term care, and all-cause mortality. In a sub-aim, we will
use a longitudinal mediation model to test whether the influence of SDoH on adverse late-life
outcomes is mediated by vision and eye health. To date, it has not been possible to carry out
nationally representative studies on the associations of VI with SDoH and key late-life outcomes due
to the lack of longitudinal and objectively measured visual function data in a national sample. Thus,
the proposed studies will address critical scientific gaps. This proposal is also highly responsive to the
National Eye Institute’s new 5-year Strategic Plan, including: (i) to gather current epidemiologic data;
(ii) to support research at the nexus of SDoH and the healthcare system; and (iii) to explore research
encompassing comorbidities. Epidemiological estimates will be made publicly available and all study
findings will be widely disseminated to maximize the impact of these studies on public health and
policy and to optimize vision and overall health and wellbeing for an aging U.S. population.
项目摘要/摘要
美国至少有1400万人是盲人或视力障碍(VI),数量
由于美国人口的衰老和增长,预计到2050年,受影响将翻一番。多数
在VI和失明的人中,年龄≥65岁的老年人。种族和少数民族也是
不成比例的影响,部分原因是医疗保健等卫生的社会决定者(SDOH)
访问,经济稳定和建筑环境的特征。特别是在以后的生活中,VI被思考
与许多不良后果有关,包括痴呆症,接受长期护理
设施,甚至死亡率。尽管如此,关于SDOH如何影响
视力和眼睛健康,以及视力如何影响晚期的结果,由于缺乏
数据:(i)是纵向的; (ii)是美国人口的代表; (iii)包含目标
评估视觉功能; (iv)样品老年人。在拟议的项目中,我们将
使用NIH资助的国家健康和衰老的新收集的愿景数据来解决此障碍
趋势研究(NHATS),一项持续的全国代表性小组研究,> 7,000名成年人≥65岁
年。在2021年,NHATS开始年度测量距离和近似视力和对比度
灵敏度。在拟议的研究的AIM 1中,我们使用NHATS数据提供了有史以来的首次估计
国家一级的VI和失明事件以及国家患病率估计
按年龄,性别,种族和种族分层。在AIM 2中,我们将评估
SDOH关于视力健康。为此,我们将利用NHATS的SDOH的个人级指标,以及
NIH资助的国家邻里数据档案存档中的邻里水平调查员
到NHATS。在AIM 3中,我们将研究VI和失明对
痴呆症的发展,长期护理中的安置以及全因死亡率。在一个子aim中,我们将
使用纵向调解模型测试SDOH对不良后期的影响
结果是由视力和眼睛健康介导的。迄今为止,不可能进行
关于VI与SDOH和关键的晚期结局的全国代表性研究
在国家样本中缺乏纵向和客观测量的视觉功能数据。那,
拟议的研究将解决关键的科学差距。该提议也对
国家眼科研究所的新的5年战略计划,包括:(i)收集当前的流行病学数据;
(ii)支持SDOH和医疗保健系统Nexus的研究; (iii)探索研究
包括合并症。流行病学估计将公开可用,所有研究
调查结果将被广泛传播,以最大化这些研究对公共卫生和
政策,以优化美国老年人口的远见,整体健康和福祉。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Joshua Robert Ehrlich其他文献
Joshua Robert Ehrlich的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Joshua Robert Ehrlich', 18)}}的其他基金
Longitudinal Study of Health and Ageing in Kenya (LOSHAK)
肯尼亚健康与老龄化纵向研究 (LOSHAK)
- 批准号:
10427945 - 财政年份:2022
- 资助金额:
$ 66.16万 - 项目类别:
Building Non-Communicable Eye Disease Research Capacity in India
在印度建设非传染性眼病研究能力
- 批准号:
10676301 - 财政年份:2021
- 资助金额:
$ 66.16万 - 项目类别:
Addressing Low Vision due to Severe Peripheral Field Loss: Development and Validation of a Patient-Centered Outcome Measure
解决因严重周边视野丧失导致的低视力问题:以患者为中心的结果测量的开发和验证
- 批准号:
9294683 - 财政年份:2017
- 资助金额:
$ 66.16万 - 项目类别:
Addressing Low Vision due to Severe Peripheral Field Loss: Development and Validation of a Patient-Centered Outcome Measure
解决因严重周边视野丧失导致的低视力问题:以患者为中心的结果测量的开发和验证
- 批准号:
10237987 - 财政年份:2017
- 资助金额:
$ 66.16万 - 项目类别:
相似海外基金
ACTFAST: Urban and Rural Trauma Centers RE-AIM at Firearm Injury Prevention
ACTFAST:城乡创伤中心重新瞄准枪支伤害预防
- 批准号:
10812044 - 财政年份:2023
- 资助金额:
$ 66.16万 - 项目类别:
The WUSTL PREP post-bacc program to enhance doctoral readiness in neuroscience
WUSTL PREP post bacc 项目旨在提高神经科学博士的准备程度
- 批准号:
10611674 - 财政年份:2023
- 资助金额:
$ 66.16万 - 项目类别:
Sustainability determinants of an intervention to identify clinical deterioration and improve childhood cancer survival in low-resource hospitals
在资源匮乏的医院中识别临床恶化并提高儿童癌症生存率的干预措施的可持续性决定因素
- 批准号:
10562780 - 财政年份:2023
- 资助金额:
$ 66.16万 - 项目类别:
Adaption of the Transition of Care Model for Post-Discharge HIV-NCD care in Malawi
马拉维出院后艾滋病毒非传染性疾病护理的护理模式转变
- 批准号:
10750007 - 财政年份:2023
- 资助金额:
$ 66.16万 - 项目类别:
Structural Racism and Discrimination in the Expansion of Hospital Stroke Care Capacity: A Multi-Level Analysis on Access to Care, Treatment, and Outcomes
扩大医院中风护理能力中的结构性种族主义和歧视:对获得护理、治疗和结果的多层次分析
- 批准号:
10473300 - 财政年份:2022
- 资助金额:
$ 66.16万 - 项目类别: